abstract |
(57) [Summary]nThe present invention generally relates to transgenic flower florets. More specifically, the present invention relates to transgenic roses, carnations that have been genetically modified to allow the expression of flavonoid 3 ', 5'-hydroxylase, thereby allowing manipulation of intermediates in the flavonoid pathway. And turned to chrysanthemum. |